TP53 and colorectal carcinoma: It is, in fact, down-regulated in tumor tissues and positively correlated with disease-free survival; it is able to hinder CRC recurrence, restraining cell growth, migration and invasion, triggering cell apoptosis and cell cycle arrest in a p53-dependent manner [35].